Shufro Rose & Co. LLC Sells 49,600 Shares of Opko Health Inc. (OPK) Posted by Mary Kom on Feb 5th, 2019 OPK stock traded down $0.66 during mid-day trading on Tuesday, hitting $2.86. The stock had a trading volume of 13,521,703 shares, compared to its average volume of 3,585,074. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.91 and a quick ratio of 0.78. Opko Health Inc. has a 1-year low of $2.34 and a 1-year high of $6.40. The firm has a market cap of $2.06 billion, a P/E ratio of -9.84 and a beta of 2.09. Opko Health (NASDAQ:OPK) last issued its earnings results on Friday, November 9th. The biotechnology company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. The company had revenue of $250.00 million for the quarter, compared to analyst estimates of $264.04 million. Opko Health had a negative return on equity of 8.68% and a negative net margin of 30.24%. The business’s revenue was up 1.6% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.08) EPS. As a group, research analysts expect that Opko Health Inc. will post -0.22 EPS for the current year. Several research analysts have recently issued reports on the company. Zacks Investment Research downgraded Opko Health from a “buy” rating to a “hold” rating in a research note on Monday. ValuEngine raised Opko Health from a “sell” rating to a “hold” rating in a report on Wednesday, January 2nd. Finally, Barrington Research reaffirmed a “buy” rating and set a $7.00 target price on shares of Opko Health in a report on Monday, November 12th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and an average target price of $9.50. In other Opko Health news, CEO Phillip Md Et Al Frost bought 100,000 shares of the firm’s stock in a transaction that occurred on Saturday, December 28th. The stock was purchased at an average price of $3.13 per share, for a total transaction of $313,000.00. Following the purchase, the chief executive officer now directly owns 3,068,951 shares in the company, valued at $9,605,816.63. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In the last three months, insiders have bought 640,000 shares of company stock worth $2,024,500. 42.74% of the stock is currently owned by insiders.
